WCN26-7242 A CASE OF MEMBRANOUS NEPHROPATHY WITH NULL SODIUM-GLUCOSE COTRANSPORTER 2 (SGLT2) PROTEIN EXPRESSION

Read full text Summarise with VIRAT
Authors: Yuya Suzuki, Takuo Hirose, Ayaka Kamada, Takahito Kaburaki, Kentaro Yano, Risa Ishikawa, Hiroki Ito, Wako Yumura, Takefumi Mori
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The sodium–glucose cotransporter 2 (SGLT2) is expressed in the brush border of proximal tubular cells and plays a key role in renal glucose reabsorption. SGLT2 inhibitors are widely used for the treatment of chronic kidney disease and heart failure due to their proven cardio-renal protective effects. However, information on SGLT2 protein expression in human kidneys remains limited. We report the first case of primary membranous nephropathy (MN) associated with a nearly complete loss of SGLT2 expression, accompanied by reversible glycosuria after treatment.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Chronic Kidney Disease and Diabetes Ion Transport and Channel Regulation

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105625–105625
Publication date
25 March 2026
Language
EN